Literature DB >> 20554220

Cytokine dependent and independent iNKT cell activation.

Emma C Reilly1, Jack R Wands, Laurent Brossay.   

Abstract

Invariant NKT (iNKT) cells have been extensively studied throughout the last decade due to their ability to polarize and amplify the downstream immune response. Only recently however, have the various mechanisms underlying NKT cell activation begun to unfold. iNKT cells have the ability to respond as innate immune cells with minimal TCR involvement as well as through direct TCR recognition of glycolipid antigens. Additionally, the existence of several subsets of iNKT cells creates the potential for other unique pathways, which are not yet clearly defined. Here, we provide an overview of the known mechanisms of invariant NKT cell activation, focusing on cytokine driven pathways and the resulting cytokine responses. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554220      PMCID: PMC2914806          DOI: 10.1016/j.cyto.2010.04.016

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  71 in total

1.  A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement.

Authors:  M C Leite-De-Moraes; A Hameg; A Arnould; F Machavoine; Y Koezuka; E Schneider; A Herbelin; M Dy
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

2.  The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.

Authors:  Elvire Bourgeois; Linh Pham Van; Michel Samson; Séverine Diem; Anne Barra; Stéphane Roga; Jean-Marc Gombert; Elke Schneider; Michel Dy; Pierre Gourdy; Jean-Philippe Girard; André Herbelin
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

3.  Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions.

Authors:  Jean-Marc Doisne; Chantal Becourt; Latiffa Amniai; Nadia Duarte; Jean-Benoît Le Luduec; Gérard Eberl; Kamel Benlagha
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

4.  Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells.

Authors:  Tommy R Gardner; Qingling Chen; Yijun Jin; Maureen N Ajuebor
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

5.  Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.

Authors:  Barbara A Sullivan; Niranjana A Nagarajan; Gerhard Wingender; Jing Wang; Iain Scott; Moriya Tsuji; Richard W Franck; Steven A Porcelli; Dirk M Zajonc; Mitchell Kronenberg
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

6.  Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB.

Authors:  Philippe Stock; Vincent Lombardi; Viola Kohlrautz; Omid Akbari
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Aging promotes neutrophil-induced mortality by augmenting IL-17 production during viral infection.

Authors:  Heather W Stout-Delgado; Wei Du; Anushree C Shirali; Carmen J Booth; Daniel R Goldstein
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

8.  In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.

Authors:  K Benlagha; A Weiss; A Beavis; L Teyton; A Bendelac
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

9.  Recognition of lyso-phospholipids by human natural killer T lymphocytes.

Authors:  Lisa M Fox; Daryl G Cox; Jennifer L Lockridge; Xiaohua Wang; Xiuxu Chen; Louise Scharf; David L Trott; Rachel M Ndonye; Natacha Veerapen; Gurdyal S Besra; Amy R Howell; Mark E Cook; Erin J Adams; William H Hildebrand; Jenny E Gumperz
Journal:  PLoS Biol       Date:  2009-10-27       Impact factor: 8.029

10.  Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.

Authors:  Jin S Im; Pooja Arora; Gabriel Bricard; Alberto Molano; Manjunatha M Venkataswamy; Ian Baine; Elliot S Jerud; Michael F Goldberg; Andres Baena; Karl O A Yu; Rachel M Ndonye; Amy R Howell; Weiming Yuan; Peter Cresswell; Young-Tae Chang; Petr A Illarionov; Gurdyal S Besra; Steven A Porcelli
Journal:  Immunity       Date:  2009-06-19       Impact factor: 31.745

View more
  24 in total

1.  Involvement of interleukin-18 in the pathogenesis of human eosinophilic esophagitis.

Authors:  Rituraj Niranjan; Priya Rajavelu; Sathisha Upparahalli Ventateshaiah; Jai Shankar Shukla; Asifa Zaidi; Siddesha Jalahalli Mariswamy; Jochen Mattner; Ilana Fortgang; Monika Kowalczyk; Luis Balart; Anshi Shukla; Anil Mishra
Journal:  Clin Immunol       Date:  2015-01-28       Impact factor: 3.969

2.  NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion Injury.

Authors:  Ashish K Sharma; Damien J LaPar; Matthew L Stone; Yunge Zhao; Christopher K Mehta; Irving L Kron; Victor E Laubach
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

3.  Impacts of the MHC class I-like XNC10 and innate-like T cells on tumor tolerance and rejection in the amphibian Xenopus.

Authors:  Maureen Banach; Eva-Stina Edholm; Xavier Gonzalez; Abdellatif Benraiss; Jacques Robert
Journal:  Carcinogenesis       Date:  2019-07-20       Impact factor: 4.944

Review 4.  Purinergic regulation of the immune system.

Authors:  Caglar Cekic; Joel Linden
Journal:  Nat Rev Immunol       Date:  2016-03       Impact factor: 53.106

Review 5.  Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.

Authors:  Mark A Exley; Lydia Lynch; Bindu Varghese; Michael Nowak; Nadia Alatrakchi; Steven P Balk
Journal:  Clin Immunol       Date:  2011-05-13       Impact factor: 3.969

6.  Role of SHIP1 in Invariant NKT Cell Development and Functions.

Authors:  Courtney K Anderson; Alexander I Salter; Leon E Toussaint; Emma C Reilly; Céline Fugère; Neetu Srivastava; William G Kerr; Laurent Brossay
Journal:  J Immunol       Date:  2015-07-31       Impact factor: 5.422

7.  Herpes Simplex Virus 1 Specifically Targets Human CD1d Antigen Presentation To Enhance Its Pathogenicity.

Authors:  Ping Rao; Xiangshu Wen; Jae Ho Lo; Seil Kim; Xin Li; Siyang Chen; Xiaotian Feng; Omid Akbari; Weiming Yuan
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

Review 8.  The functions of type I and type II natural killer T cells in inflammatory bowel diseases.

Authors:  Chia-Min Liao; Michael I Zimmer; Chyung-Ru Wang
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

Review 9.  Therapeutic strategies for sickle cell disease: towards a multi-agent approach.

Authors:  Marilyn J Telen; Punam Malik; Gregory M Vercellotti
Journal:  Nat Rev Drug Discov       Date:  2019-02       Impact factor: 84.694

10.  Bystander activation of iNKT cells occurs during conventional T-cell alloresponses.

Authors:  J-P Jukes; K J Wood; N D Jones
Journal:  Am J Transplant       Date:  2011-11-09       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.